Eur J Gastroenterol Hepatol 2004, 16:669–674.PubMedCrossRef 6. Mulder SJ, Mulder-Bos GC: Most probable origin of coeliac disease is low

immune globulin A in the intestine caused by malfunction of Peyer’s patches. Med Hypotheses 2006, 66:757–762.PubMedCrossRef 7. Barbato M, Iebba V, Conte MP, Schippa S, Borrelli O, Maiella G, Longhi C, Totino V, Viola F, Cucchiara S: Role of gut microbiota in the pathogenesis of celiac disease. Dig Liver Dis 2008, 40:A42.CrossRef 8. Sanz Y, Sánchez E, De Palma G, Medina M, Marcos A, Nova E: Indigenous gut microbiota, probiotics, and coeliac disease. In Child Nutrition & Physiology. Edited by: Overton LT, Ewente MR. New York: Nova Science Publishers, Inc; 2008:211–224. 9. Tjellström B, Stenhammar L, Högberg L, Fälth-Magnusson K, Magnusson KE, Midtvedt T, Sundqvist T, Norin E: Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol 2005, 100:2784–2788.PubMedCrossRef Seliciclib clinical trial 10. Sanz Y, Sanchez E, Marzotto M, Calabuig M, Torriani S, Dellaglio F: Differences in faecal bacterial communities in coeliac and healthy children as

detected by PCR and denaturing H 89 solubility dmso gradient gel electrophoresis. FEMS Immunol Med Microbiol 2007, 51:562–568.PubMedCrossRef 11. Collado MC, Calabuig M, Sanz Y: Differences between the fecal microbiota of coeliac infants and healthy controls. Curr Issues Intest Microbiol 2007, 8:9–14.PubMed 12. Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y: Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 2007, 56:1669–1674.PubMedCrossRef 13. van der Waaij LA, Limburg PC, Mesander G, van derWaaij D: In vivo IgA coating of anaerobic bacteria in human faeces. Gut 1996, 38:348–354.PubMedCrossRef 14. Pastor RO, Lopez San RA, Albeniz AE, de la Hera MA, Ripoll SE, Albillos MA: Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:269–277.CrossRef 15. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, Jahn HK, Dunay IR, Moter A, Gescher DM, Schumann RR, Göbel UB, Liesenfeld O: Gram-negative

bacteria mafosfamide aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol 2006, 177:8785–8795.PubMed 16. Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T, Kamada N, Sakuraba A, Yajima T, Higuchi H, Inoue N, Ogata H, Iwao Y, Nomoto K, Tanaka R, Hibi T: Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 2008, 298:463–472.PubMedCrossRef 17. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB: VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005, 100:1539–1546.PubMedCrossRef 18.